Clinica di Ematologia Istituto oncologico della Svizzera Italiana
Clinica di Ematologia Istituto oncologico della Svizzera Italiana
Bellinzona, Switzerland1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome. | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Active, not recruiting | Phase 3 | 2025-09-30 | NCT05181592 |